Huminig, Ayisha .

HRN: 27-31-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2026
CEFUROXIME 750MG (VIAL)
01/28/2026
02/04/2026
IV
470mg
Q 8 Hours
T/C Bacterial Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines